The effect of the glucose-insulin-potassium solution on the p-wave dispersion of the heart failure patients

Basit Öğe Kaydı
dc.contributor.authorErcan, Suleyman
dc.contributor.authorOylumlu, Muhammed
dc.contributor.authorOylumlu, Mustafa
dc.contributor.authorSoydinc, Serdar
dc.contributor.authorDavutoglu, Vedat
dc.date.accessioned2024-04-24T17:27:39Z
dc.date.available2024-04-24T17:27:39Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractAtrial fibrillation (AF) has adverse effects on the disease prognosis and the functional capacity during heart failure. P wave dispersion has been considered as one of the most important parameters predicting the development of AF. It is known that glucose-insulin-potassium (GIK) infusion has favorable metabolic and hemodynamic effects. The aim of our study is to investigate the effects of GIK infusion on P wave dispersion in patients with heart failure. In our study, 30 patients with the diagnosis of heart failure and a low left ventricular ejection fraction (EF<40%) were included. Fifteen patients randomized to GIK solution (20 U insulin and 60 mEq KCl in 20% 500 ml dextrose solution) in 8 hours for consecutive 3 days (Group I) and other 15 patients were randomized to isotonic NaCl solution in addition to the conventional therapy (Group II, control). Twelve-lead electrocardiography were recorded in all patients to detect the P wave dispersion. P wave dispersion was calculated between the Group I and Group II patients before the study respectively (19.4 +/- 7.5 and 19 +/- 6.3) (p>0.05). In Group I, P wave dispersion measured after GIK infusion was 13 +/- 6.5. In group II, P wave dispersion measured after 0.9% NaCl solution infusion were 20.4 +/- 6.4. P wave dispersion was found significantly lower in patients administrated GIK infusion (p=0.001). According to the present study, we showed that the P wave dispersion which predicts AF was significantly lower in the patients treated with GIK than in the control group.en_US
dc.identifier.doi10.5455/GMJ-30-2012-91
dc.identifier.endpage89en_US
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue2en_US
dc.identifier.startpage85en_US
dc.identifier.urihttps://doi.org/10.5455/GMJ-30-2012-91
dc.identifier.urihttps://hdl.handle.net/11468/20118
dc.identifier.volume18en_US
dc.identifier.wosWOS:000439206200008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherAves Press Ltden_US
dc.relation.ispartofEuropean Journal of Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGlucose-Insulin-Potassiumen_US
dc.subjectHeart Failureen_US
dc.subjectP Wave Dispersionen_US
dc.titleThe effect of the glucose-insulin-potassium solution on the p-wave dispersion of the heart failure patientsen_US
dc.titleThe effect of the glucose-insulin-potassium solution on the p-wave dispersion of the heart failure patients
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu